Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ironwood Poised To Move Linaclotide To Phase III In IBS-C

Oct 08 2008

Related Content

Forest Teams Up With Microbia On IBS-C Agent Linaclotide

Sep 17 2007

Novartis Further Restricts Access To Zelnorm

Apr 03 2008

Sucampo/Takeda’s Amitiza Gains IBS-C Indication

Apr 29 2008

Forest’s Linaclotide, Aclidinium Ready For Phase III

May 21 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window